ONdrugDelivery has a reputation for dependable, cutting-edge content, regular contributions and loyal support from leading experts from companies large and small, and an engaged, global print and digital readership. With a commercial perspective, the series has been specifically designed, based on the publisher’s deep knowledge and clear understanding of the science and business of drug delivery, to meet the needs of its readers worldwide. The unique ONdrugDelivery publications offer a valuable lead in two important ways: Those in the pharmaceutical and biotechnology sectors, whose role it is to seek novel delivery systems and pair these with their own companies’ research and product development programmes, agree. These are ONdrugDelivery’s readers. They absolutely require this information from the drug delivery sector. ONdrugDelivery fulfils this requirement absolutely. Subscribe Contribute Media PackDrug delivery is the science and business of delivering pharmaceutically active ingredients to the required site in the body, in the right quantities, at the correct time and in the most effective and convenient manner.
ONdrugDelivery exists to provide its readers throughout global pharma and biopharma, with the latest, most pertinent, high-quality industry information, intelligence and insights we possibly can, about the ideas, technologies, services and products the drug delivery sector is developing.
Established in 2004 by Guy Furness, ONdrugDelivery is trusted throughout the pharma / biotech industry, and known as the topic-specific b2b drug delivery publication that focuses on one area within the field of drug delivery in each issue.
Frederick Furness Publishing
ONdrugDelivery is published by Frederick Furness Publishing, a specialist in providing niche drug delivery industry information and intelligence.
“The key to the success of ONdrugDelivery is simple. Detailed knowledge of drug delivery enables us to focus each issue on specialist topics within the industry. In the past, drug delivery industry publishing lacked this level of speciality. This is the need that we meet and this is what gives ONdrugDelivery a real edge.”
Guy Furness, Owner, Frederick Furness Publishing Ltd
Drug delivery is a specialised subject, not only in scientific and technological terms but, crucially, in terms of the particular way that companies involved in drug delivery must interact with other businesses. Therefore, the manner in which information about drug delivery is presented and disseminated must, for it to be valuable to readers, be decided with the particular characteristics of the drug delivery market in mind, and by considering carefully the specific requirements of the individuals and organisations who need to know about drug delivery.
There is an important difference, which quickly becomes apparent to those who begin a relationship with Frederick Furness Publishing. We focus purely on drug delivery because we believe that the only way to provide useful, relevant and truly valuable information about this sector is through a deep understanding of it, a fervent enthusiasm for it and a strong belief in it.
Frederick Furness Publishing has:
- a worldwide reputation as an established, reliable and informed source of up-to-date information on the science and business of the global drug delivery industry
- a global reach and the access to key sources necessary to provide timely, comprehensive information and intelligence of the highest quality.
- a vast network of close, long-standing contacts including industry executives and scientists, leading academics and financial analysts
- proven ability to convey detailed technical and commercial information in the most efficient, digestible and useful form.